Cleared Traditional

MPS ACACIA POWER INJECTABLE INFUSION SET (K090809) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K090809 · Mps Acacia · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
34d
Days
Class 2
Risk

K090809 is an FDA 510(k) clearance for the MPS ACACIA POWER INJECTABLE INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Mps Acacia (Brea, US). The FDA issued a Cleared decision on April 28, 2009 after a review of 34 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Mps Acacia devices

Submission Details

510(k) Number K090809 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2009
Decision Date April 28, 2009
Days to Decision 34 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 129d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 239
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K090809.
ACCU-CHEK ULTRFLEX INFUSION SET
K101196 · Roche Diagnostics Corp. · Aug 2010
DUAL LUER LOCK CAP, MODEL 2C6250
K101385 · Baxter Healthcare Corp · Jun 2010
A6 LUER ACCESS DEVICE
K083723 · B.Braun Medical, Inc. · Jun 2009
INTRAVENOUS POWER INJECTOR EXTENSION SET
K090134 · C.R. Bard, Inc. · Apr 2009
MISER CONTRAST MANAGEMENT SYSTEM
K083576 · Merit Medical Systems, Inc. · Dec 2008
POWERLOC CLEAR SAFETY INFUSION SET
K082306 · C.R. Bard, Inc. · Aug 2008